Bayer AG BAYN

Overview

Bayer Aktiengesellschaft, established in 1863 and headquartered in Leverkusen, operates globally as a life science company. With subsidiaries worldwide, it functions across three main segments: Pharmaceuticals, Consumer Health, and Crop Science. Bayer's commitment to innovation and health is evidenced through its extensive collaboration with entities like Acuitas Therapeutics, Inc., Peking University, the Swiss Tropical and Public Health Institute, bit.bio Ltd., Hologic, Inc., Twist Bioscience Corporation, and CrossBay Medical Inc, along with a partnership with Thermo Fisher Scientific. The company's diverse product distribution network includes wholesalers, pharmacies, online retailers, and hospitals, as well as direct sales to farmers.

Products and Services

• Pharmaceuticals:

  This segment delivers prescription products focusing on cardiology, women's health care, and specialty therapeutics in oncology, hematology, and ophthalmology. It includes diagnostic imaging equipment and digital solutions, contrast agents, and pioneering work in cell and gene therapy. Collaboration efforts, such as with Acuitas Therapeutics, Inc., and Peking University, bolster its research and development in this vital area.

• Consumer Health:

  Under this division, Bayer markets an array of nonprescription, over-the-counter medicines aimed at self-medication and self-care. The product range encompasses nutritional supplements, solutions for allergy, cough, cold, dermatology, pain, cardiovascular risk prevention, and digestive health. This segment reflects Bayer’s dedication to supporting day-to-day health and well-being.

• Crop Science:

  This segment is dedicated to advancing agriculture through seeds, improved plant traits, chemical and biological crop protection products, and digital farming solutions. It focuses on breeding, propagation, and the production/processing of seeds, including seed dressing. Bayer's commitment to sustainability and innovation in agriculture is further supported by its services to farmers, aiming to enhance productivity and environmental conservation.

• Collaborations and Partnerships:

  Bayer actively engages in strategic collaborations to enhance its product offerings and research capabilities. This includes working with the Swiss Tropical and Public Health Institute on developing emodepside to tackle soil-transmitted helminth infections and partnering with bit.bio Ltd for cell therapy innovations. Additionally, collaborations with Hologic, Inc. focus on improving diagnostic imaging for breast cancer detection, whereas its partnership with Twist Bioscience Corporation is centered around developing antibody-based pharmaceuticals. Bayer's collaboration with Thermo Fisher Scientific further underscores its commitment to advancing life sciences.